Efficacy and Safety of Baricitinib in Patients with Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic DMARDs and/or Biological DMARDs: Data from a Local Registry José Rosas, José Miguel Senabre-Gallego, Gregorio Santos-Soler, José Antonio Bernal, Ana Pons Bas

Predictors of response to biologic therapies in rheumatoid arthritis Lara M. Chaves Chaparro, Juan Salvatierra Ossorio, Enrique Raya Álvarez

Epigenetic therapies, a step beyond biologics for rheumatoid arthritis Olga Sánchez-Pernaute